Safety and Effectiveness of 3 Doses of Crofelemer Compared to Placebo in the Treatment of HIV Associated Diarrhea - Related Studies

Safety and Effectiveness of 3 Doses of Crofelemer Compared to Placebo in the Treatment of HIV Associated Diarrhea (ADVENT)

This study is currently recruiting participants.

Study NCT00547898. Last updated on November 19, 2008. Information provided by Napo Pharmaceuticals, Inc.

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Diarrhea
		HIV Infections
		Gastrointestinal Disease

2	Additional conditions recognized in this trial
		Acquired Immunodeficiency Syndrome
		Gastrointestinal Diseases
		Infection

3	More general conditions related to this trial
		Digestive System Diseases
		Immune System Diseases
		Immunologic Deficiency Syndromes
		Lentivirus Infections
		Retroviridae Infections
		RNA Virus Infections
		Sexually Transmitted Diseases
		Sexually Transmitted Diseases, Viral
		Signs and Symptoms
		Signs and Symptoms, Digestive
		Slow Virus Diseases
		Virus Diseases

4	Interventions listed in this trial
		crofelemer

5	Sponsors listed in this trial
		Napo Pharmaceuticals, Inc.